Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medagate Links OTC “Purse” To Managed Accounts, Offers Discounts

This article was originally published in The Tan Sheet

Executive Summary

Medagate’s Dual Value Card links payments from consumers’ managed accounts to receiving discounts on OTCs and other health and wellness products. Employers and insurers have the option of setting up the cards as pre-tax savings accounts, including with a separately funded “purse” for OTCs.

You may also be interested in...



Medagate Recruits OTC Firms To Help Reach Medicare Clients

OTC firms are in talks to build marketing campaigns that tie their products to Medagate’s purchasing card offered to Medicare clients, the firm says. Marketing can “help drive purchasing behavior into one brand versus another,” says Medagate VP David Vielehr.

Medagate Recruits OTC Firms To Help Reach Medicare Clients

OTC firms are in talks to build marketing campaigns that tie their products to Medagate’s purchasing card offered to Medicare clients, the firm says. Marketing can “help drive purchasing behavior into one brand versus another,” says Medagate VP David Vielehr.

Hearing Targets OTC Eligibility For Health Savings Funds

Louisiana Republican Rep. Charles Boustany Jr. says physician groups suggest the OTC prescription requirement imposes an unreasonable administrative burden, causes longer waits for appointments and increases health care costs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106199

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel